Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BBNX

Beta Bionics Inc

May 22 • 04:00PM ET

11.82

+1.21 11.40 %

Healthcare • Medical Devices • USA • Small • NASD

May 21, 4:40 PMBeta Bionics targets full Mint patch pump launch by end of Q2 2027, pending FDA clearance

Peers: TNDM PODD MDT SENS DXCM

| Held by: VTI IWM VXF IWO SCHA VTWO IHI XHE SNSR ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.51	Insider Own	24.93%	Shs Outstand	44.56M	Perf Week	24.95%
Market Cap	526.72M	Forward P/E	-	EPS next Y	-2.11	Insider Trans	-0.45%	Shs Float	33.45M	Perf Month	3.41%
Enterprise Value	334.01M	PEG	-	EPS next Q	-0.58	Inst Own	98.06%	Short Float	18.52%	Perf Quarter	-14.10%
Income	-66.44M	P/S	4.78	EPS this Y	-19.34%	Inst Trans	-1.29%	Short Ratio	6.09	Perf Half Y	-57.36%
Sales	110.24M	P/B	1.94	EPS next Y	2.45%	ROA	-20.68%	Short Interest	6.19M	Perf YTD	-61.21%
Book/sh	6.09	P/C	2.64	EPS next 5Y	5.89%	ROE	-22.71%	52W High	32.71 -63.86%	Perf Year	-23.79%
Cash/sh	4.48	P/FCF	-	EPS past 3/5Y	-6.13% -	ROIC	-24.04%	52W Low	8.80 34.32%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	724.29% -	Gross Margin	57.15%	Volatility	8.81% 6.29%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.03	EPS Y/Y TTM	7.83%	Oper. Margin	-70.13%	ATR (14)	0.78	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.67	Sales Y/Y TTM	57.87%	Profit Margin	-60.27%	RSI (14)	63.07	Recom	1.55
Dividend Gr. 3/5Y	- -	Current Ratio	10.69	EPS Q/Q	25.46%	SMA20	17.38%	Beta	3.27	Target Price	19.36
Payout	-	Debt/Eq	0.03	Sales Q/Q	56.62%	SMA50	11.58%	Rel Volume	1.11	Prev Close	10.61
Employees	423	LT Debt/Eq	0.02	Earnings	Apr 21 AMC	SMA200	-37.02%	Avg Volume	1.02M	Price	11.82
IPO	Jan 30, 2025	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.53% 2.52%	Trades		Volume	1,128,210	Change	11.40%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-09-26	Initiated	UBS	Buy	$24
Jan-27-26	Initiated	TD Cowen	Hold	$17
Jan-09-26	Downgrade	BofA Securities	Buy → Neutral
Oct-21-25	Resumed	Stifel	Buy	$26
Oct-01-25	Upgrade	Goldman	Neutral → Buy	$26
Jun-16-25	Initiated	Truist	Buy	$26
Jun-12-25	Initiated	Lake Street	Buy	$30
May-30-25	Initiated	Wolfe Research	Outperform	$20
May-30-25	Initiated	Goldman	Neutral	$16
Feb-24-25	Initiated	Stifel	Buy	$25
Feb-24-25	Initiated	Piper Sandler	Overweight	$26
Feb-24-25	Initiated	Leerink Partners	Outperform	$28
Feb-24-25	Initiated	Lake Street	Buy	$30
Feb-24-25	Initiated	BofA Securities	Buy
Feb-20-25	Initiated	Robert W. Baird	Neutral	$20
Feb-20-25	Initiated	Ladenburg Thalmann	Neutral	$20

Show Previous Ratings

May-21-26 04:04PM	Beta Bionics Updates Commercialization Timeline Expectations for Mint, its Patch Pump in Development (GlobeNewswire) +11.40%
May-14-26 05:05PM	Robert Bruce's Strategic Moves: A Closer Look at Beta Bionics Inc's Impactful Addition (GuruFocus.com)
Apr-27-26 04:25PM	Beta Bionics to Present at the Bank of America Securities Health Care Conference (GlobeNewswire) -5.35%
Apr-22-26 08:30AM	Beta Bionics, Inc. Q1 2026 Earnings Call Summary (Moby)
03:04AM	Beta Bionics Inc (BBNX) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amid Operational ... (GuruFocus.com)
04:03PM	Loading…
Apr-21-26 04:03PM	Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance (GlobeNewswire)
Apr-20-26 09:20AM	Beta Bionics Inc (BBNX) Q1 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Mar-31-26 06:00AM	Beta Bionics Introduces Bionic Insights in Bionic Reports - Transforming How Clinicians Understand and Optimize Diabetes Care (GlobeNewswire)
Mar-30-26 04:11PM	Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026 (GlobeNewswire) -8.36%
Mar-06-26 04:50AM	Beta Bionics Details iLet Automation Strategy, Sales Expansion and Mint Patch Pump Timeline at Conference (MarketBeat)
Feb-20-26 05:00AM	Senseonics launches automated insulin dosing system with 1-year CGM (MedTech Dive)
Feb-19-26 04:05PM	Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-18-26 08:30AM	Beta Bionics, Inc. Q4 2025 Earnings Call Summary (Moby)
12:01AM	Beta Bionics Inc (BBNX) Q4 2025 Earnings Call Highlights: Record Growth Amid Regulatory Challenges (GuruFocus.com)
Feb-17-26 07:00PM	Beta Bionics Q4 Earnings Call Highlights (MarketBeat)
05:25PM	Loading…
05:25PM	Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 (GlobeNewswire)
Feb-16-26 07:20AM	Earnings To Watch: Beta Bionics Inc (BBNX) Reports Q4 2025 Result (GuruFocus.com)
Feb-10-26 10:00AM	Will Beta Bionics, Inc. (BBNX) Report Negative Earnings Next Week? What You Should Know (Zacks) +6.56%
Feb-09-26 09:36AM	Oracle gets upgrade and downgrade: Wall Street's top analyst calls (The Fly) +6.04%
Feb-02-26 09:21AM	Beta Bionics receives FDA warning letter (MedTech Dive)
Jan-15-26 04:03PM	Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 (GlobeNewswire)
Jan-09-26 12:02PM	Beta Bionics Key KPI Miss Targets, Analyst Flags Valuation Risks (Benzinga) -37.04%
Jan-08-26 04:04PM	Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics (GlobeNewswire)
Dec-09-25 07:10AM	Medline seeks $5.37bn in largest healthcare IPO of 2025 (Medical Device Network)
Dec-08-25 07:45AM	Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 (GlobeNewswire)
Nov-03-25 04:08PM	Beta Bionics Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Oct-30-25 03:25PM	Beta Bionics Inc (BBNX) Q3 2025 Earnings Call Highlights: Record Growth and Strategic Challenges (GuruFocus.com)
Oct-28-25 06:30PM	Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +10.34%
04:02PM	Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance (GlobeNewswire)
09:38AM	Loading…
Oct-27-25 09:38AM	What to Expect from Beta Bionics Inc (BBNX) Q3 2025 Earnings (GuruFocus.com) +13.37%
Oct-16-25 04:33PM	Goldman Sachs Upgrades Beta Bionics (BBNX) to Buy, Raises PT to $26 on Strong Growth and Market Outlook (Insider Monkey)
Oct-09-25 08:00AM	Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025 (GlobeNewswire)
Aug-21-25 08:00AM	Beta Bionics Announces Participation at Upcoming Investor Conferences (GlobeNewswire) +10.39%
Jul-30-25 03:17AM	Beta Bionics Inc (BBNX) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com) +14.32%
Jul-29-25 04:02PM	Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance (GlobeNewswire)
03:20PM	Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival (Bloomberg)
Jul-04-25 02:43AM	Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas (Insider Monkey)
Jul-02-25 07:30AM	Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 (GlobeNewswire)
Jun-24-25 03:59PM	Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions (GlobeNewswire)
06:56AM	ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors (MedTech Dive)
Jun-23-25 11:20AM	BBNX Stock May Gain From Abbott Deal to Advance iLet Integration (Zacks) -11.68%
Jun-20-25 07:06AM	5 things to watch at the ADAs Scientific Sessions (MedTech Dive)
Jun-19-25 07:00AM	Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor (GlobeNewswire)
Jun-16-25 10:21AM	Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth (Investing.com)
Jun-02-25 05:01AM	Beta Bionics CEO, CFO on how to take a company public (MedTech Dive) +8.41%
May-29-25 05:44AM	The medtech IPO window is finally open. Or is it? (MedTech Dive) +6.44%
May-07-25 03:22AM	Beta Bionics Inc (BBNX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com) +26.61%
May-06-25 04:02PM	Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 (GlobeNewswire)
May-01-25 08:00AM	Beta Bionics to Present at the Bank of America Securities Health Care Conference (GlobeNewswire)
Apr-24-25 11:44AM	Beta Bionics: Slowing Down Or Being Conservative? (Seeking Alpha) +5.74%
Apr-19-25 05:30AM	ClearBridge Small Cap Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-16-25 04:05PM	Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 (GlobeNewswire)
Apr-09-25 07:30AM	Beta Bionics to Host Investor Event on June 22, 2025 (GlobeNewswire) +21.63%
Mar-28-25 06:00AM	Newly public Beta Bionics reports sales surge; Dexcom hires CCO (MedTech Dive) -7.58%
Mar-27-25 04:45PM	Beta Bionics Announces Board Appointment of Gerard Michel (GlobeNewswire)
Mar-25-25 04:02PM	Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 (GlobeNewswire) -13.60%
Mar-03-25 12:59PM	Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently (Insider Monkey)
Feb-27-25 07:00AM	Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 (GlobeNewswire)
Feb-21-25 09:35AM	Palantir initiated, Roku upgraded: Wall Streets top analyst calls (TipRanks)
Jan-31-25 05:56PM	Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
06:34AM	Beta Bionics raises $204M in IPO (MedTech Dive)
Jan-30-25 12:55PM	Beta Bionics raises $204m to kickstart medtech IPO season (Medical Device Network)
Jan-29-25 10:34PM	Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering (GlobeNewswire)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

PresidentMr. Sean T. Saint PE

CFOMr. Stephen H. Feider

Chief Product OfficerMr. Mike Mensinger

Vice President of OperationsMr. David Henderson

Head of Investor RelationsBlake Beber

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CHRISTINA JONES	Director	May 21 '26	Proposed Sale	10.11	1,998	20,200		May 21 04:30 PM
ADAM LEZACK	Director	May 21 '26	Proposed Sale	10.11	1,998	20,200		May 21 04:30 PM
Hopman Mark	Chief Commercial Officer	Dec 04 '25	Sale	30.66	2,061	63,192	136,216	Mar 16 07:55 PM
Hopman Mark	Chief Commercial Officer	Dec 02 '25	Sale	29.34	856	25,112	138,277	Mar 16 07:55 PM
Russell Steven Jon	Chief Medical Officer	Dec 02 '25	Sale	29.34	1,025	30,069	178,071	Mar 16 07:55 PM
Hopman Mark	Chief Commercial Officer	Mar 04 '26	Sale	11.57	353	4,084	139,133	Mar 05 07:30 PM
Mark Hopman	Officer	Mar 04 '26	Proposed Sale	11.57	353	4,084		Mar 04 06:02 PM
Michael R. Mensinger	Officer	Mar 02 '26	Proposed Sale	12.52	1,064	13,321		Mar 04 04:58 PM
Stephen Feider	Officer	Mar 02 '26	Proposed Sale	12.52	1,428	17,879		Mar 04 04:56 PM
Sean Saint	Officer	Mar 02 '26	Proposed Sale	12.52	3,384	42,368		Mar 04 04:54 PM
Hopman Mark	Chief Commercial Officer	Mar 02 '26	Sale	12.36	834	10,310	139,486	Mar 03 06:45 PM
Russell Steven Jon	Chief Medical Officer	Mar 02 '26	Sale	12.36	1,026	12,683	179,096	Mar 03 06:45 PM
Mensinger Mike	Chief Product Officer	Mar 02 '26	Sale	12.36	1,064	13,153	188,793	Mar 03 06:45 PM
Feider Stephen	Chief Financial Officer	Mar 02 '26	Sale	12.36	1,428	17,652	172,729	Mar 03 06:45 PM
Saint Sean	President & CEO	Mar 02 '26	Sale	12.36	3,384	41,832	437,809	Mar 03 06:45 PM
Mensinger Mike	Chief Product Officer	Jan 06 '26	Sale	30.10	2,200	66,221	80,752	Jan 07 04:16 PM
Mensinger Mike	Chief Product Officer	Jan 02 '26	Sale	29.61	7,800	230,950	82,952	Jan 05 06:05 PM
Feider Stephen	Chief Financial Officer	Jan 02 '26	Option Exercise	5.10	20,000	102,000	62,614	Jan 05 06:03 PM
Feider Stephen	Chief Financial Officer	Jan 02 '26	Sale	29.53	20,000	590,680	42,614	Jan 05 06:03 PM
MICHAEL MENSINGER	Officer	Jan 02 '26	Proposed Sale	30.47	10,000	304,700		Jan 02 04:27 PM
Stephen Feider	Officer	Jan 02 '26	Proposed Sale	29.53	20,000	590,680		Jan 02 04:17 PM
Mark Hopman	Officer	Dec 04 '25	Proposed Sale	30.66	2,061	63,192		Dec 04 04:41 PM
Mensinger Mike	Chief Product Officer	Dec 02 '25	Sale	29.34	1,063	31,184	90,752	Dec 04 04:20 PM
Feider Stephen	Chief Financial Officer	Dec 02 '25	Sale	29.34	1,427	41,862	42,614	Dec 04 04:20 PM
Saint Sean	President & CEO	Dec 02 '25	Sale	29.34	3,278	96,163	97,924	Dec 04 04:20 PM
Sean Saint	Officer	Dec 02 '25	Proposed Sale	29.34	3,278	96,163		Dec 04 04:14 PM
Michael R. Mensinger	Officer	Dec 02 '25	Proposed Sale	29.34	1,063	31,184		Dec 04 04:12 PM
Stephen Feider	Officer	Dec 02 '25	Proposed Sale	29.34	1,427	41,862		Dec 04 04:11 PM
Lezack Adam	Director	Dec 01 '25	Sale	29.55	1,406	41,543	8,435	Dec 02 04:20 PM
Palasis Maria	Director	Dec 01 '25	Sale	29.55	1,406	41,552	8,435	Dec 02 04:20 PM
Lezack Adam	Director	Oct 31 '25	Sale	26.87	1,406	37,780	9,841	Nov 05 09:45 PM
Palasis Maria	Director	Oct 31 '25	Sale	26.91	1,406	37,834	9,841	Nov 05 09:45 PM
ADAM LEZACK	Director	Oct 31 '25	Proposed Sale	26.78	2,812	75,305		Oct 31 04:14 PM
MARIA PALASIS	Director	Oct 31 '25	Proposed Sale	26.78	2,812	75,305		Oct 31 04:13 PM
Feider Stephen	Chief Financial Officer	Oct 03 '25	Option Exercise	5.10	4,982	25,408	49,023	Oct 07 04:15 PM
Feider Stephen	Chief Financial Officer	Oct 03 '25	Sale	21.69	4,982	108,076	44,041	Oct 07 04:15 PM
Feider Stephen	Chief Financial Officer	Oct 01 '25	Option Exercise	5.10	15,018	76,592	59,059	Oct 03 04:31 PM
Feider Stephen	Chief Financial Officer	Oct 01 '25	Sale	20.76	15,018	311,806	44,041	Oct 03 04:31 PM
Stephen Feider	Officer	Oct 03 '25	Proposed Sale	21.69	4,982	108,076		Oct 03 03:34 PM
Stephen Feider	Officer	Oct 01 '25	Proposed Sale	20.76	15,018	311,837		Oct 01 04:42 PM
Feider Stephen	Chief Financial Officer	Sep 08 '25	Option Exercise	5.10	9,900	50,490	53,941	Sep 09 04:12 PM
Feider Stephen	Chief Financial Officer	Sep 08 '25	Sale	21.13	9,900	209,151	44,041	Sep 09 04:12 PM
Hopman Mark	Chief Commercial Officer	Sep 05 '25	Option Exercise	5.10	11,411	58,196	42,626	Sep 08 06:15 PM
Hopman Mark	Chief Commercial Officer	Sep 04 '25	Option Exercise	5.10	4,749	24,220	38,033	Sep 08 06:15 PM
Hopman Mark	Chief Commercial Officer	Sep 05 '25	Sale	20.56	11,411	234,657	31,215	Sep 08 06:15 PM
Hopman Mark	Chief Commercial Officer	Sep 04 '25	Sale	19.97	6,818	136,180	31,215	Sep 08 06:15 PM
Feider Stephen	Chief Financial Officer	Sep 05 '25	Option Exercise	5.10	100	510	44,141	Sep 08 06:15 PM
Feider Stephen	Chief Financial Officer	Sep 05 '25	Sale	21.00	100	2,100	44,041	Sep 08 06:15 PM
Feider Stephen	Officer	Sep 08 '25	Proposed Sale	21.13	9,900	209,152		Sep 08 02:23 PM
Hopman Mark	Officer	Sep 05 '25	Proposed Sale	20.56	11,411	234,657		Sep 05 05:24 PM
Feider Stephen	Officer	Sep 05 '25	Proposed Sale	21.00	100	2,100		Sep 05 05:12 PM
Saint Sean	President & CEO	Sep 02 '25	Sale	18.86	3,359	63,361	101,202	Sep 04 06:45 PM
Russell Steven Jon	Chief Medical Officer	Sep 02 '25	Sale	18.86	1,015	19,146	71,017	Sep 04 06:45 PM
Mensinger Mike	Chief Product Officer	Sep 02 '25	Sale	18.86	1,089	20,542	91,815	Sep 04 06:45 PM
Hopman Mark	Chief Commercial Officer	Sep 02 '25	Sale	18.86	848	15,996	33,284	Sep 04 06:45 PM
Feider Stephen	Chief Financial Officer	Sep 02 '25	Sale	18.86	1,462	27,578	44,041	Sep 04 06:45 PM
Hopman Mark	Officer	Sep 04 '25	Proposed Sale	19.97	6,818	136,180		Sep 04 04:33 PM
Feider Stephen	Chief Financial Officer	Aug 22 '25	Option Exercise	5.10	4,413	22,506	49,916	Aug 26 04:29 PM
Feider Stephen	Chief Financial Officer	Aug 22 '25	Sale	17.01	4,413	75,083	45,503	Aug 26 04:29 PM
Feider Stephen	Officer	Aug 22 '25	Proposed Sale	17.01	4,413	75,083		Aug 22 11:10 AM
Hopman Mark	Chief Commercial Officer	Aug 19 '25	Option Exercise	5.10	16,158	82,406	50,290	Aug 20 09:30 PM
Hopman Mark	Chief Commercial Officer	Aug 19 '25	Sale	16.61	16,158	268,376	34,132	Aug 20 09:30 PM
Feider Stephen	Chief Financial Officer	Aug 19 '25	Option Exercise	5.10	5,587	28,494	51,090	Aug 20 09:30 PM
Feider Stephen	Chief Financial Officer	Aug 19 '25	Sale	17.03	5,587	95,172	45,503	Aug 20 09:30 PM
Feider Stephen	Officer	Aug 19 '25	Proposed Sale	17.03	5,587	95,172		Aug 19 05:41 PM
Hopman Mark	Officer	Aug 19 '25	Proposed Sale	16.61	16,158	268,376		Aug 19 05:30 PM
Sean Saint	Officer	Jun 02 '25	Proposed Sale	17.89	3,439	61,524		Jun 09 08:30 PM
Hopman Mark	Chief Commercial Officer	Jun 02 '25	Sale	17.89	868	15,529	34,132	Jun 04 07:30 PM
Russell Steven Jon	Chief Medical Officer	Jun 02 '25	Sale	17.89	1,039	18,588	72,032	Jun 04 07:30 PM
Mensinger Mike	Chief Product Officer	Jun 02 '25	Sale	17.89	1,115	19,948	92,904	Jun 04 07:30 PM
Feider Stephen	Chief Financial Officer	Jun 02 '25	Sale	17.89	1,497	26,783	45,503	Jun 04 07:30 PM
Saint Sean	President & CEO	Jun 02 '25	Sale	17.89	3,439	61,526	104,561	Jun 04 07:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BBNX

Beta Bionics Inc

Upgrade your Finviz experience